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HeartAn understanding of heart development is critical in any systems biology approach to cardiovascular disease.
The interpretation of data generated from high-throughput technologies (such asmicroarray and proteomics)
is also essential to this approach. However, characterizing the role of genes in the processes underlying heart
development and cardiovascular disease involves the non-trivial task of data analysis and integration of
previous knowledge. The Gene Ontology (GO) Consortium provides structured controlled biological
vocabularies that are used to summarize previous functional knowledge for gene products across all species.
One aspect of GO describes biological processes, such as development and signaling.
In order to support high-throughput cardiovascular research, we have initiated an effort to fully describe heart
development in GO; expanding the number of GO terms describing heart development from 12 to over 280.
This new ontology describes heart morphogenesis, the differentiation of speciﬁc cardiac cell types, and the
involvement of signaling pathways in heart development. This work also aligns GO with the current views of
the heart development research community and its representation in the literature. This extension of GO
allows gene product annotators to comprehensively capture the genetic program leading to the
developmental progression of the heart. This will enable users to integrate heart development data across
species, resulting in the comprehensive retrieval of information about this subject.
The revised GO structure, combined with gene product annotations, should improve the interpretation of data
from high-throughput methods in a variety of cardiovascular research areas, including heart development,
congenital cardiac disease, and cardiac stem cell research. Additionally, we invite the heart development
community to contribute to the expansion of this important dataset for the beneﬁt of future research in this
area.r Genetics, Rayne Institute, 5
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Forming as the result of an elegant coordination of integrated
processes, the heart is one of the ﬁrst organs to develop in a vertebrate
embryo. Understanding this developmental process is critical to the
understanding of cardiovascular disease (CVD), a leading cause of
mortality worldwide (Batsis and Lopez-Jimenez, 2010). One aspect of
CVD is damaged heart tissue, and the possibility of using stem cells to
repair a heart, is an active area of research (Bollini et al., 2011).
However, to fully understand how to repair a heart we must ﬁrst
understand the processes by which a heart is formed. Heart
development is a complex process controlled by a multitude of
coordinated cellular processes resulting in proper patterns of cell
10 V.K. Khodiyar et al. / Developmental Biology 354 (2011) 9–17differentiation and tissue morphogenesis (Abu-Issa and Kirby, 2007;
Dyer and Kirby, 2009). The events in the process are still being
identiﬁed, thus the study of genes and proteins involved in
cardiovascular development is an important research area. As with
any multi-genic process, there is an important role for high-
throughput methods to characterize the genes and proteins involved
in both developmental and disease processes. However, interpreta-
tion of high-throughput data with regard to previously established
work is a non-trivial task, associated with a need for categorization of
gene functions to enable data analysis. To assist with the interpreta-
tion of these data, the Gene Ontology Consortium (GOC) provides a
robust hierarchical controlled vocabulary, the Gene Ontology (GO)
(Ashburner et al., 2000). Individually each GO term can be applied to
gene products across all species to summarize individual experiments.
However, the power of GO lies in the fact that it is a categorization of
gene product characteristics, rather than a categorization of gene
products themselves. Thus, large numbers of gene products can be
grouped on the basis of their characteristics, as deﬁned by GO terms.
Many high-throughput analysis tools have been developed for this
purpose (Hendrickson et al., 2008; Malik et al., 2010; Werner, 2008).
GO currently contains over 33,000 terms and is routinely used for the
analysis of large datasets (Colak et al., 2009; Herbert et al., 2009; Mace
et al., 2009).
The GOC comprises of GO editors who develop the ontology, and
GO annotators who read the primary literature and create annotations
using the ontology (Gene Ontology Consortium, 2009). The two
groups of curators work closely together. As a result GO terms are
continuously examined, evaluated and tested during the annotation
process based on the experimental literature. The GOC has set up
several mechanisms for handling ontology issues. We utilize a
SourceForge tracker for ontology questions, have a ‘help’ resource
available from the GO web site and provide contact information for
curator interest groups who coordinate biological areas of ontology
development (see box). There are more than a dozen model organism
databases (MOD) represented in the GOC, which use GO to annotate
the gene products of their speciﬁc organism. Additionally there are
other annotation groups focusing on speciﬁc areas of biology. The
BHF-UCL (British Heart Foundation-University College London) GO
team focuses on cardiovascular biology and has the speciﬁc remit of
annotating human proteins involved in cardiovascular processes and
disease (Lovering et al., 2008). An advantage to having a specialized
annotation group like the BHF-UCL group is that it allows for
development of a whole branch of the ontology alongside the creation
of gene annotations using the new ontology terms. GO annotators
read the primary literature and create GO annotations using a variety
of evidence codes that describe the nature of the experiments that
support the annotation. In practice annotations to developmental
processes are mostly derived from direct assays, mutational studies or
gene interaction studies. Annotators are cautious about usingThere are multiple ways in which the research community can
contact curators on any aspect of GO
The GOC helpdesk can be contacted by completing the online
form at www.geneontology.org/GO.contacts.shtml.
The GOC uses the SourceForge software for issues to be submitted
and tracked. This software is publicly accessible and further
details can be found at geneontology.sf.net.
Each MOD and curation group also has its own website with
contact details for the curators working within that group. Details
of how to contact the BHF-UCL team, can be found at www.
cardiovasculargeneontology.com.expression data for GO annotations since expression may correlate
with a process, but not necessarily be actively involved in the process.
In general, there are two ways in which ontology development can
be coordinated with annotation: 1) terms can be requested in-
dividually as annotators ﬁnd need for them; 2) large-scale develop-
ment of the ontology can be undertaken in anticipation of the terms
needed for annotation. In practice, we have found that the latter
method is very efﬁcient for developing focused areas of the ontology
(Diehl et al., 2007; Feltrin et al., 2009; Maccagnan et al., 2010).
Speciﬁcally, we ﬁnd that collaboration between expert annotators,
ontology developers and experimental biologists working in the
relevant ﬁeld is a productive way to create an accurate and complete
representation of an area of biology in the shortest amount of time.
In order to establish the groundwork for an expansion of the
representation of GO biological processes involved in heart develop-
ment, an initial meeting was held between gene annotators (from
the BHF-UCL GO team and several model-organism databases), GOC
ontology developers and cardiac development experts (all authors of
this paper). At the start of the work, there were 12 terms in GO that
represented all of heart development.Work during themeeting, as well
as subsequent revisions and discussions have resulted in the addition of
281 new terms to date (see Supplemental Table for full list of new
terms). Thesenew termshave been added toGOandare fully integrated
with relationships to other developmental processes in the existing
biological processes ontology, and all additional parent terms. The new
terms are publically available as part of the current version of GO. GO
now includes terms describing an anatomical representation of heart
development (such as the valves and the heart chambers), as well as
terms that describe speciﬁc types of processes that contribute to heart
development (such as cell differentiation and signaling pathways). In
this article we introduce the new heart development Gene Ontology,
demonstrate how it is used for annotations and invite the heart
development community to contribute to this important resource.
A gene ontology primer
Gene Ontology (GO) is a controlled vocabulary that is used to
classify the biological characteristics of gene products. GO terms
describe three characteristics, Biological Process (BP), Molecular
Function (MF) and Cellular Component (CC). BP terms describe the
general process a gene product is involved in, MF terms describe the
speciﬁc molecular function of a gene product and CC terms describe
the subcellular compartment in which a gene product is found. This
work focused on the expansion of the BP part of GO, which encom-
passes all developmental processes.
Gene annotators use experimentally supported data from pub-
lished literature to associate speciﬁc GO terms with the genes that
have been shown to bear the attributes described by the GO term.
Taken as a whole, the set of annotations to a given gene product aims
to describe the totality of what is currently known about that gene
product's role in biology, while an individual annotation describes the
results of a single experiment. Annotators use their biological
knowledge alongside information presented in the paper to judge
the most speciﬁc term possible for each annotation. For example,
individual experiments have shown that the homeobox NKX2-5 gene
product takes part in the process of cardiac muscle cell differentiation
(GO:0055007; BP) (Tanaka et al., 1999), has transcription factor
activity (GO:0003700; MF) (Kasahara and Izumo, 1999) and is found
in the nucleus (GO:0005634; CC) (Zhu et al., 2000). Thus the NKX2-5
gene product has been annotated to each of those terms. Additionally
gene products may have multiple functions, often take part in more
than one process and can be found in multiple subcellular compart-
ments. GO allows a single gene product to be annotated to any
number of terms from each of the three ontologies.
GO terms are structured in directed acyclic graphs (DAG), where
each term can have multiple relationships to broader ‘parent’ and
11V.K. Khodiyar et al. / Developmental Biology 354 (2011) 9–17more speciﬁc ‘child’ terms. The parent and child terms have speciﬁc
relationships with each other. In GO, there are seven types of relation-
ships (GeneOntologyConsortium, 2009; Smith et al., 2005), ofwhichﬁve
are relevant to the heart development ontology. The ‘is_a’ relationship
means that a child term is always a type of its parent term; for example
heart development (GO:0007507) is a type of organ development
(GO:0048513). The ‘part_of’ relationship means that the child term is
always a part of the parent term; for example cell migration involved in
vasculogenesis (GO:0035441) is part of vasculogenesis (GO:0001570).
The ‘regulates’, ‘positively_regulates’, and ‘negatively_regulates’ relation-
ships signify that the children have a regulatory effect on the parent; for
example the term negative regulation of cardiac muscle tissue
development (GO:0055026) has a ‘negatively_regulates’ relationship to
the term cardiac muscle tissue development (GO:0048738). To illustrate
how terms and relationships are used in GO, Fig. 1 shows that the term
vasculogenesis (GO:0001570) has two direct ancestors, cell differentia-Fig. 1. The ancestor chart for GO terms vasculogenesis and angiogenesis. The graph show
ancestor terms. The root of this ontology is the ‘biological process’ term, thus all the ter
(GO:0001570) is automatically associated with the term blood vessel morphogenesis, since vtion (GO:0030154) and blood vessel morphogenesis (GO:0048514).
Vasculogenesis ‘is a’ type of cell differentiation and is also ‘part of’ the
process of blood vessel morphogenesis.
An important beneﬁt of building a DAG, rather than a ﬂat-list of
controlled vocabulary terms, is that relationships can be used to make
inferences from one term to another. For example, vasculogenesis
(GO:0001570) is part of blood vessel morphogenesis (GO:0048514)
and blood vessel morphogenesis (GO:0048514) is part of blood vessel
development (GO:0001568). Therefore, because the ‘part_of’ rela-
tionship is transitive, vasculogenesis (GO:0001570) can also be
considered to be a part of blood vessel development (GO:0001568),
and does not require a direct link between the two terms. This
transitive nature is very useful when using GO to ﬁnd gene products
annotated as being involved in a particular process; for example a
search for gene products annotated to blood vessel morphogenesis
(GO:0048514) will include those annotated directly to the mores the terms vasculogenesis (GO:0001570), angiogenesis (GO:0001525) and all of their
ms shown here are biological processes. A gene product annotated to vasculogenesis
asculogenesis is a child of blood vessel morphogenesis.
Fig. 2. Anatomy of a GO term. QuickGO view of GO (www.ebi.ac.uk/QuickGO) illustrates how each GO term has a unique GO ID number. The term name describes the overall
concept, which is supplemented by what is often a very detailed deﬁnition. Some terms also have synonyms to aid searching.
12 V.K. Khodiyar et al. / Developmental Biology 354 (2011) 9–17speciﬁc processes of vasculogenesis (GO:0001570) and angiogenesis
(GO:0001525), both of which are a part of blood vessel morphogen-
esis (GO:0048514).
Each GO term has several different components (Fig. 2). The GO ID
is unique to each term. The deﬁnition is a textual description of what
the term means and in many cases disambiguates the use of identical
identical words or phrases used by researchers to mean different
things. Additionally the placement of the term within the ontology
also provides a necessary deﬁnition through the terms' relationships
with its parents. For example the term lateral ventricle development
(GO:0021670) may at ﬁrst glance be ambiguous, but upon viewing
the ontology it is clear that this term is a descendant of central
nervous system development (GO:0007417), and thus ‘ventricle’ in
this context refers to a brain ventricle and not a heart ventricle.
GO allows for the description of processes that occur at multiple
levels of biology: i) the organ level, ii) themulticellular (tissue) level and
iii) the level of the single cell. It also allows for the description of generic
processes that are used inmultipleways toaccomplisha givenobjective.
The developmental process section of the biological process ontology
allows for the description of developmental events either from an
anatomical perspective or from a process perspective. Standard
developmental terms such as cell differentiation (GO:0030154) are
deﬁned generically and are then used consistently to describe the
process in the context of all of the different processes in which it is
involved (Hill et al., 2010). The following sections illustrate how the
newly createdontologycanbeused todescribe theheart developmental
processes that occur at each of these three levels; heart morphogenesis
at the organ level, cell differentiation in the heart at the cellular level,
and signalingpathways todescribe interactions between cells thatmake
up tissues.
The terms and relationships in the ontology are carefully chosen so
that regardless of the species the ontology is always correct. Species-
neutrality enables experimentally supported annotations in model
organisms, to be transferred to human gene products, if appropriate.
For example, based on the observation that expression of mouse
Mesp1 in embryonic stem cells (ESCs) results in transcriptional
regulation of key genes controlling early mesoderm and endoderm
cell fates and promotes the progression of cells toward a cardiac fate(Bondue et al., 2008). One of the terms that was used to annotate the
mouse Mesp1 gene product is cardiac cell fate determination
(GO:0060913). At the time of writing there are 26 experimentally
supported annotations associated with the mouse Mesp1 gene
product, whereas there are 10 such annotations associated to the
human MESP1 gene product. The unique mouse annotations have
been transferred to the orthologous human protein, thus enhancing
our knowledge about how the orthologous gene products might be
involved in human biology or disease.
Heart morphogenesis
In GO,morphogenesis is used to describe the initial formation of an
anatomical structure and its subsequent shaping in an anatomical
context. Because the ontology does not contain temporal relation-
ships, GO does not describe lineage relationships between anatomical
structures. Although often embedded in the deﬁnition of a term,
lineage relationships themselves are not speciﬁed in the ontology. An
important aspect in the creation of the development domain of GO is
identifying when a structure begins to exist and what processes lead
to its formation. In addition, GO developers need to reﬂect the
prevailing thought of the scientiﬁc community of a given ﬁeld. This
approach allows GO to be used in a practical manner as it is aligned
with current scientiﬁc thought. The heart is formed from a distinct
group of cells (distinguishable from the surrounding cell population
only by the proteins expressed) that make up the heart ﬁelds. These
cells proliferate and migrate to form distinct subpopulations of cells,
which then form the discrete substructures of the heart, for example
the valves and the chambers. GO reﬂects that the speciﬁcation of the
heart ﬁeld is one of the initial processes of heart development and
contains terms for primary heart ﬁeld speciﬁcation (GO:0003138) and
secondary heart ﬁeld speciﬁcation (GO:0003139). Both of these terms
are types of a more generic heart ﬁeld speciﬁcation (GO:0003128).
The induction process whereby the mesoderm, endoderm, and ecto-
derm interact are not part of the formation of the heart per se, but
rather positively regulate its formation. The rationale behind this
decision is that when this inductive process is occurring, the heart has
not formed and the delineation of the ﬁeld is the ﬁrst step in the
cell fate 
determination
developmental 
programmed cell death   
developmental cell 
growth
cell 
morphogenesis
cell 
maturation
cell development
cell differentiation
cell fate 
specification
cell fate commitment
Fig. 3. Cell differentiation ontology. Gene products specify what a cell is going to be through the process of cell fate commitment (GO:0045165) and subsequently expressed gene
products allow the cell to become so through the process of cell development (GO:0048468). All the terms shown in this ﬁgure have a ‘part_of ’ relationship to their parent term.
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inductive interactions in the development domain of the ontology
(Hill et al., 2010). Other terms that are part of the morphogenesis of
the heart reﬂect both the morphogenesis of anatomical parts of the
heart such as cardiogenic plate morphogenesis (GO:0003142) and
endocardial cushion morphogenesis (GO:0003203), or conserved
processes that contribute to the shaping of the structure itself such as
apoptosis involved in heart morphogenesis (GO:0003278) and
growth involved in heart morphogenesis (GO:0003241). The latter
category of terms allows users of GO to search for gene products that
might be conserved in apoptosis or growth involved morphogenesis
of other anatomical structures.Cell differentiation in the heart
Much of development at the cellular level can be considered to be
successive cell differentiation events that eventually lead to terminally
differentiated cells that contribute to the functioning of a mature
anatomical structure. GO describes cell differentiation in two parts. First
an undifferentiated cell somehow decideswhat it will become and then
in the second step the cell undergoes the actual process of becomingTable 1
The 26 newly created heart-speciﬁc cell type terms currently in GO. This is not an
exhaustive list, and other cell types will be added when needed for new annotations.
Gene Ontology term name Gene Ontology ID
Atrial cardiac muscle cell differentiation GO:0003167
Atrioventricular bundle cell differentiation GO:0003168
Atrioventricular node cell differentiation GO:0003255
Cardiac blood vessel endothelial cell differentiation GO:0003292
Cardiac endothelial cell differentiation GO:0003293
Cardiac ﬁbroblast cell differentiation GO:0003348
Cardiac glial cell differentiation GO:0003349
Cardiac muscle cell differentiation GO:0007513
Cardiac muscle cell myoblast differentiation GO:0010002
Cardiac neuron differentiation GO:0051890
Cardiac Purkinje ﬁber cell differentiation GO:0051891
Cardiac septum cell differentiation GO:0051892
Cardiac vascular smooth muscle cell differentiation GO:0055007
Cardioblast differentiation GO:0055011
Endocardial cell differentiation GO:0055012
Endocardial precursor cell differentiation GO:0060379
Epicardium-derived cardiac endothelial cell differentiation GO:0060920
Epicardium-derived cardiac ﬁbroblast cell differentiation GO:0060921
Epicardium-derived cardiac vascular smooth muscle
cell differentiation
GO:0060922
Heart valve cell differentiation GO:0060932
His-Purkinje system cell differentiation GO:0060935
Neural crest-derived cardiac ﬁbroblast cell differentiation GO:0060938
Neural crest-derived cardiac glial cell differentiation GO:0060942
Pacemaker cell differentiation GO:0060945
Pericardial cell differentiation GO:0060946
Sinoatrial node cell differentiation GO:0060947
Ventricular cardiac muscle cell differentiation GO:0060950differentiated. In GO, the term cell differentiation (GO:0030154) is the
parent of the terms cell fate commitment (GO:0045165) that describes
how a cell decides what to become, and cell development
(GO:0048468) that describes how a cell undergoes the actual dif-
ferentiation process. The relationship between these terms and further
descendants of these terms are shown in Fig. 3. Theway that GOdeﬁnes
cell differentiation, and in particular the phrases used in the deﬁnitions
of these terms, is discussed in greater depth in a review of Gene
Ontology and developmental biology (Hill et al., 2010).
This structure allows GO to describe the differentiation of any cell
type in the heart. As a result, we have included 26 cell type terms
speciﬁc to the heart in the revised ontology (Table 1). These range
from very general cell type terms like cardiac ﬁbroblast cell dif-
ferentiation (GO:0060935) to very speciﬁc cell type terms like atrio-
ventricular bundle cell differentiation (GO:0003167).
The structure that is now in place will permit gene product
annotations to be integrated into knowledge about not only the
generic types of cells that cardiac cells represent but also integrated
into the way they play speciﬁc roles in the development of the heart.
For example, atrioventricular bundle cell differentiation is related to
generalized cardiac muscle cell differentiation as well as to the de-
velopment of the cardiac conduction system (Fig. 4).
The arrangement of the cell differentiation terms allows for the
placement of new terms easily into the ontology. It also allows for the
detailed annotation of gene products at a level of detail that is supported
by the experimental data. For example, in the context of ESC dif-
ferentiation, when ESCs are transfected with POU5F1 cDNA and
stimulated with BMP2, pluripotency is lost, the cells express SOX17 and
adopt a cardiovascular fate (Stefanovic et al., 2009). However, without
the BMP2 signal, transfection with POU5F1 cDNA maintains the
pluripotency of the ESC. Thus, POU5F1 speciﬁes a cardiac cell fate only
if the cell is subject to a speciﬁc environment, and so POU5F1 was
annotatedwith cardiac cell fate speciﬁcation (GO:0060912). (Themouse
Pou5f1 and human POU5F1 gene products respectively have 68 and 18
additional experimentally supported annotations). On the other hand,
once thehumanESCexpresses SOX17, it is committed to a cardiac cell fate
regardless of the environment (Stefanovic et al., 2009); thus SOX17 was
annotated with cardiac cell fate determination (GO:0060913). (The
mouse Sox17 and human SOX17 gene products respectively have 15 and
11 other experimentally supported annotations).
Signaling pathways in heart development
The revised heart development ontology allows for the annotation
of gene products that describe signaling processes between different
types of heart cells. Terms like endodermal–mesodermal cell signaling
involved in heart induction (GO:0003134) describe signaling process-
eswhere it is known that the cells of the endoderm signal to cells of the
mesoderm, but the molecular nature of the signaling is unknown.
Where the molecular nature of the signaling is known, we are able to
create terms for the speciﬁc pathways. So farwehave created terms for
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Fig. 4. An example of the relationship between speciﬁc cell types and the role the cell plays in heart development. GO allows atrioventricular bundle cells to have a direct ‘is_a’
relationship to generalized cardiac cells, as well a ‘part_of ’ relationship to cardiac conduction. I indicates a term has an ‘is_a’ relationship to it's parent term, and P indicates a ‘part_of ’
relationship.
14 V.K. Khodiyar et al. / Developmental Biology 354 (2011) 9–17the BMP, hedgehog, FGF, Notch, TGF-beta and WNT signaling
pathways as children of cell surface receptor linked signaling pathway
involved in heart development (GO:0061311). By creating these high-
level generic terms, we have built the framework for the addition of
more speciﬁc terms, involving these and other signaling pathways, ashea
c
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Fig. 5. The Wnt signaling ontology illustrates the way in which GO can be used to represen
have an ‘is_a’ relationship to their parent term.needed to annotate new data. For example, it has shown that heart
induction is a result of several signaling pathways, the BMP signaling
pathway (Dyer and Kirby, 2009), the Notch pathway (MacGrogan
et al., 2010) and the FGF receptor signaling pathway (Samuel and
Latinkic, 2009); whilst the canonical Wnt receptor signaling pathwaynegative 
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t signaling pathways involved in heart development. All the terms shown in this ﬁgure
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As an example of the types of signaling pathway termsGO can support,
we have created terms such as BMP signaling pathway involved in
heart induction (GO:0003130), ﬁbroblast growth factor receptor
signaling pathway involved in heart induction (GO:0003135) and
Notch signaling pathway involved in heart induction (GO:0003137),
all as ‘part of’ heart induction (GO:0003129) (Bondue et al., 2008;
Lough et al., 1996; Schlange et al., 2000).
We have also created the term negative regulation of heart
induction by canonical Wnt receptor signaling pathway
(GO:0003136) to describe the role of that pathway in the process.
Annotations are made to gene products involved in each of the
pathways, and these can then be used during analysis of high-
throughput data to identify members of signaling pathways that play
roles in heart induction. For example, BMP2 induces a cardiac fate
(Stefanovic et al., 2009) and has therefore been annotated to BMP
signaling pathway involved in heart induction (GO:003130) while the
Mesp1 gene product promotes cardiovascular differentiation by
inhibiting the canonical Wnt signaling pathway (David et al., 2008),
hence Mesp1 was annotated to the term positive regulation of heart
induction by negative regulation of canonical Wnt receptor signaling
pathway (GO:0090082). This term positively regulates heart induc-
tion and therefore describes the role of theMesp1 gene product. As an
example of how we plan to handle the complexity of signaling
pathways in heart development, we have expanded theWnt-receptor
signaling portion of the ontology in detail.
As shown in Fig. 5, Wnt receptor signaling pathway involved in
heart development (GO:0003306) has two child terms, canonicalWnt
receptor signaling pathway involved in heart development
(GO:0061316) and non-canonical Wnt receptor signaling pathway
involved in heart development (GO:0061341). Based on the literature,
the canonical Wnt receptor signaling pathway involved in heart
development (GO:0061316) term has been given six child terms to
describe the role of canonical Wnt signaling in cardiac muscle cell fate
commitment (GO:0061317), cardiac neural crest cell differentiation
(GO:0061310), cardiac muscle cell proliferation (GO:0061315),
cardiac outﬂow tract cell proliferation (GO:0061324), secondary
heart ﬁeld cardioblast proliferation (GO:0003267), and heart induc-
tion (Brade et al., 2006; Kwon et al., 2007; Song et al., 2010).
We have begun using these terms for the annotation of gene
products. As detailed annotations accumulate, it will become
increasingly easy to identify all proteins that act in signaling pathways
resulting in speciﬁc developmental events in the heart. As more
experimental evidence becomes available to support the role of a
particular signaling pathway in a particular developmental event, we
will continue to expand the ontology and the associated annotations.
GO is applicable across species
GO is designed so that it can be used for the annotation of all gene
products across all species. This allows GO to be used to examine
orthologous gene products from a variety of species and to make
conclusions about conserved or diverse biological processes based on
annotations to similar or dissimilar GO terms. It also allows us to
transfer annotations from one species to another when genes appear
to have conserved functions across species (Mi et al., 2009). For
example, orthologs of TBX5 have been shown to be key players in the
patterning of the ventricle. These gene products have differential
expression patterns in the 3-chambered amphibian heart compared
to the 4-chambered mammalian and avian hearts. In the red-eared
slider turtle (Trachemys scripta elegans), the expression of Tbx5 was
homogenous throughout its single ventricle, whereas in the chick it
was restricted to the left ventricle (Koshiba-Takeuchi et al., 2009).
Furthermore, the loss of Tbx5 in the mouse ventricle resulted in the
development of a single ventricle, similar to that of the turtle
(Koshiba-Takeuchi et al., 2009). In this relatively simple scenario,the mouse and chick Tbx5 gene products are annotated to ventricular
septum development (GO:0003281) and cardiac left ventricle
formation (GO:0003218). The turtle Tbx5 gene product would be
annotated to the parent of the latter term, cardiac ventricle formation
(GO:0003211). Thus the structure of the ontology allows for the
differential annotation of orthologous gene products that take part in
related but distinct processes in different species.
However, there are also cases where different species have speciﬁc
structures. In the zebraﬁsh (Danio rerio), the bulbus arteriosus is an
elastic heart chamber that receives blood from the heart, and
maintains its ﬂow to the gill arches. There is no orthologous structure
in mammals, so we created the term bulbus arteriosus development
(GO:0003232) to capture this ﬁsh-speciﬁc process.
There are also some processes that appear to be species speciﬁc. In
the zebraﬁsh, the establishment of left/right asymmetry of the heart
tube has been observed to occur through a two step process of heart
tube displacement and rotation called ‘heart jogging’ and ‘heart
looping’ (Chen et al., 1997). The resulting left/right asymmetry of the
heart tube is reversed or otherwise disrupted in a number of zebraﬁsh
mutants affecting genes including the chd, acvr1l, smad5, bmp7a, ndr2,
foxh1, pkd2, lrrc6, spaw, and cha genes (Chen et al., 1997; Hashimoto et
al., 2004; Long et al., 2003). Experimentally supported data from such
mutants has been curated to a number of GO BP terms relating to
heart development, including heart jogging (GO:0003146), heart
looping (GO:00011947), cell migration involved in heart jogging
(GO:0003305), and determination of left/right symmetry
(GO:0007368). The process of heart jogging has not been observed
in mammals, in addition there does not appear to be an orthologous
process. Therefore, restrictions in the ontology have been created to
ensure that any annotations made to zebraﬁsh gene products to heart
jogging (GO:0003146) and its child terms cannot be transferred to
mammalian orthologs. The GOC has mechanisms in place to ensure
that inappropriate annotations are not made (Deegan et al., 2010).
Community annotation
With the new ontology structure for heart development in place,
the challenge now is to utilize the new terms in annotations and to
continue to reﬁne and add to the ontology. This is a daunting task for
MOD curators since the existing experimental literature is volumi-
nous. Manual GO annotation is a painstaking process, with a large
volume of literature to sort through and relatively few curators at each
MOD dedicated to GO annotation. One way to increase the amount of
information about how gene products play a role in heart develop-
ment is to take advantage of the orthology strategies described above.
However, the annotation effort can also be greatly helped by input
from research scientists working in collaboration with professional
curators. This exercise in ontology development is proof that input
from experts in the ﬁeld can have dramatic effects on a bioinformatics
resource such as GO. Since experimental biologists are necessarily
much more familiar with their ﬁeld of research, they know the details
and location of the experimental evidence to support a GO annotation
or a new ontology term better than a GO curator, who does not
necessarily specialize in the ﬁeld.
Research scientists can help to improve the GO annotation dataset
for heart development in a number of ways. 1) Review the
information we have captured about a gene in which they specialize,
informing us of inaccurate or missing annotations. 2) Help identify
key papers in a ﬁeld or research, resulting in the manual curation
representing the most comprehensive and accurate information. 3)
Review the ontology to be sure that it is complete and aligns with the
current thought in the ﬁeld. 4) Provide feedback about how they have
used GO in their analyses, reporting about what they liked, didn't like
or features they would like to see available. 5) Researchers could also
provide GO annotations from their own papers, this has been working
well with the Arabidopsis community (Ort and Grennan, 2008). Input
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suggestions are made ontology curators will address issues that are
raised, with help from domain experts in the ﬁeld. We suggest that a
good time for researchers to provide GO annotations would be when
proofreading accepted papers. This would ensure that the latest data
would be included in the GO annotation dataset. Annotated papers
may be cited more often, since GO is widely used in bioinformatics
analyses.
Although the GOC consists of curators working at several different
MODs in multiple different locations around the world, GO curators
communicate regularly andutilize each other's expertise. For example,
a curator working on human gene products may contact a curator
working for another MOD as needed, to annotate a paper on an
organism which is unfamiliar to them. Therefore the GO curators are
able to call upon a wide range of species-speciﬁc expertise as needed.
Additionally, GO curators are proactive about involving expert
researchers as needed to work on a particular area of the ontology,
as evidenced by the work described here and by previous ontology
development projects (Feltrin et al., 2009; Maccagnan et al., 2010).
Conclusions
In this article we have described the work that we have done to
reﬁne and expand the representation of heart development in GO. We
have expanded the heart development section of the ontology from 12
to over 250 terms. In the process, we have integrated the representation
of heart development with other cellular and developmental processes
in GO. Biological Process GO terms can now be used to interpret all
aspects of heart development processes, from an anatomical perspec-
tive, to a cell differentiation perspective, through to a cellular
perspective such as signaling. Heart development is a complex process
underpinned by multiple gene regulatory networks and signaling
pathways, and the use of GO terms can help to simplify the cate-
gorization of gene products which are important to this process.
Additionally, the fact that GO terms and their associated annotations are
freely availablemeans that this dataset is a vitally important resource for
the heart research community, from those wishing to analyze high-
throughput data (Marques et al., 2010; Tranter et al., 2010) to those
wishing to use the heart as a model for understanding how
organogenesis initiates and unfolds (Abdulla et al., 2010).
The structure we have established not only places heart develop-
ment in alignment with other developmental processes in GO, but
also allows for the interpretation of gene product annotations using
the variety of ontology structures and the detail of terms. This new
structure should prove useful for researchers in the ﬁeld who are
performing genomic studies or searching for genes that could be
involved in a given process. As the terms are used for annotation and
as researchers generate new biological knowledge, we anticipate
additional terms will need to be created. The existing mechanisms
established by the GOC for revising the ontology will continue to be
used. However, the ontology foundations presented here will permit
easy additions of new terms in the future as children of existing heart
development terms. For example the differentiation of a new cell type
can be added as a differentiation of an existing generic cell type and a
part of the development of the structure to which it contributes.
With the structure of the heart development ontology now in
place, the rate-limiting step for using GO to its full potential is the
annotation of gene products to the new terms in the ontology.
Curators from the relevant model organism databases are working
alongside the BHF-UCL GO team to screen the literature and identify
papers containing gene products that are involved in heart develop-
ment. It is at this step, and in the continued development of the
ontology where experts in the ﬁeld could help us to streamline the
process. By helping us to identify key genes, literature and areas of
the ontology on which to focus, researchers could make certain that the
limited curatorial resources available are utilized in the most efﬁcientmanner. In the end this will add to the value of our resource for the
beneﬁt of the entire cardiovascular research community.
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